课题基金 / 基金详情

SENSITIVE TEST OF GENERALIZED STEATORRHEA

SENSITIVE TEST OF GENERALIZED STEATORRHEA
广义脂肪泻的敏感测试
批准号:
2796587
负责人:
MORTEZA JANGHORBANI
金额:
$23.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 2000-09-29

项目摘要

项目成果

MORTEZA JANGHORBANI的其他基金

相关文献

中文摘要
翻译
目前脂肪泻定量评估的“黄金标准”, 在评估吸收不良时,普遍推荐72小时大便脂肪。 但却极大地未得到充分利用,因为它单调乏味,难以执行。 我们提出了一种新的方法来直接测量所有人的脂肪泻 消除了72小时大便测试的局限性的原因 保留了它的重要特征。我们的方法是基于管理 1,3-[13C]二硬脂基,2-油醇基甘油及其不可吸收标记物 用高脂肪的DyCl3餐,然后分析单人大便。这个 预计化验对脂溢性消化不良和肥胖症敏感 酸吸收不良,性价比高,并提供高度 与个体患者72小时大便脂肪呈正相关。在第一阶段,我们 证明了该方法的可行性,证明了Dy是 定量排泄,并遵循与13C相同的排泄动力学- 标有甘油三酯。在第二阶段,我们会研究 导致临床使用的实际测试的方法。我们将演示 标记的甘油三酯吸收是可重复性的,准确地反映 个别患者的脂肪泻程度,并有极好的 诊断灵敏度/特异度。开发的检测试剂盒和分析 服务将通过生物化学分析公司进行营销。 建议的商业应用: 这项研究将导致检测试剂盒和程序的可用 对于所有原因和要求的脂肪泻进行准确的定量 仅收集一张凳子。因为这一过程高度 重复性好、准确度高、使用相对简单,具有一定的适用性 在临床诊断和研究中使用。
英文摘要
The current "gold-standard" for quantitative assessment of steatorrhea, 72-h stool fat, is universally recommended in evaluation of malabsorption but vastly under-utilized because it is tedious and difficult to perform. We propose a novel approach for direct measurement of steatorrhea from all causes which eliminates the limitations of the 72-h stool test while retaining its important features. Our approach is based on administration of 1,3--[13C]distearyl, 2-oleolyl glycerol and the nonabsorbable marker DyCI3 with a high fat meal followed by analysis of a single stool. The test is expected to be sensitive to steatorrhea of maldigestion and fatty acid malabsorption, cost effective, and to provide results that are highly correlated with 72-h stool fat in individual patients. During Phase I, we demonstrated the feasibility of the approach by showing that Dy is quantitatively excreted and follows the same excretion kinetics as 13C- labeled triglyceride. During Phase II, we will study details of the approach leading to a practical test for clinical use. We will demonstrate that labeled triglyceride absorption is reproducible, accurately reflects the degree of steatorrhea in individual patients, and has excellent diagnostic sensitivity/specificity. The developed test kit and analytical services will be marketed through BioChemAnalysis Corporation. PROPOSED COMMERCIAL APPLICATION: This research will lead to the availability of a test kit and procedure for accurate quantitation of steatorrhea from all causes and requires collection of only a single stool. Because the procedure highly reproducible, accurate and relatively simple to use it will be applicable to clinical diagnostic use as well as use in research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Non-Invasive Surrogate Test of OGTT to Screen for Pre-diabetes
  • 批准号:
    7479062
  • 项目类别:
  • 资助金额:
    $20.43万
  • 财政年份:
    2008
  • 负责人:
    MORTEZA JANGHORBANI
  • 依托单位:
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
  • 批准号:
    8502434
  • 项目类别:
  • 资助金额:
    $30.12万
  • 财政年份:
    2008
  • 负责人:
    MORTEZA JANGHORBANI
  • 依托单位:
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
  • 批准号:
    8688746
  • 项目类别:
  • 资助金额:
    $30.12万
  • 财政年份:
    2008
  • 负责人:
    MORTEZA JANGHORBANI
  • 依托单位:
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients
  • 批准号:
    8314779
  • 项目类别:
  • 资助金额:
    $30.38万
  • 财政年份:
    2008
  • 负责人:
    MORTEZA JANGHORBANI
  • 依托单位: